Maxcyte

Maxcyte: global cell therapy company providing proprietary non-viral cell engineering technology for the next generation of cell-based therapies including gene editing and immuno-oncology. MaxCyte has a blue chip client base, 120+ issued licences, and potential $800m+ pre-commercial milestone potential from existing licenses. In addition, MaxCyte is seeking independent financing for CARMA (mRNA-based CAR platform) to establish it as a separate therapeutics company and allow MaxCyte to focus on its core cell-engineering business.
Sector/Industry:
Healthcare/Medical Diagnostics & Research
Characteristics:
Based in...
US - South Atlantic
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Oncology
Listing
Europe, Public
Market Cap
<100MM
Therapeutic Modalities
Cell Therapy, Gene editing, Gene Therapy
Website:
Address:
22 Firstfield Road
Suite 110
Gaithersburg, MD 20878
United States

Company Participants at Solebury Trout Virtual Global Healthcare Conference Series

  • Douglas Doerfler, President & CEO

Top 10 Holders of MaxCyte, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Casdin Capital LLC 21.97 11,281,334 0.00 Stakes 10/30/20
River & Mercantile Asset Management LLP 13.34 6,849,975 0.00 Stakes 10/30/20
Canaccord Genuity Wealth Ltd. 6.38 3,275,350 0.00 Stakes 10/30/20
Unicorn Asset Management Ltd. 5.88 3,017,857 0.00 Stakes 10/30/20
BlackRock Investment Management (UK) Ltd. 4.15 2,799,279 0.00 Stakes 1/21/20
Legal & General Investment Management Ltd. 3.80 2,562,752 0.00 Stakes 1/21/20
Chelverton Asset Management Ltd. 3.56 2,400,000 0.00 Funds 6/30/20
Artisan Partners LP 3.22 1,652,546 0.00 Funds 9/30/20
Amati Global Investors Ltd. 2.65 1,359,728 0.00 Funds 12/31/20
Amati Global Investors Ltd. (Venture Capital) 1.92 986,693 0.00 Funds 7/31/20

Top 10 Holders of MaxCyte, Inc. Reg S

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Amati Global Investors Ltd. 12.37 1,225,000 0.00 Funds 12/31/20
River & Mercantile Asset Management LLP 4.38 433,500 0.00 Funds 12/31/20

Top 10 Holders of MaxCyte, Inc. TEMP

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BlackRock Investment Management (UK) Ltd. 3.68 219,041 0.00 Stakes 1/21/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.